Human Papillomavirus Vaccination and Human Papillomavirus-Associated Cancer Rates Within Florida Counties

被引:7
作者
Staras, Stephanie A. S. [1 ,2 ]
Huo, Tianyao [1 ]
Rothbard, Sarah M. [1 ]
Hall, Jaclyn M. [1 ,2 ]
Cho, Hee D. [1 ]
Guo, Yi [1 ]
Richardson, Eric [1 ]
Salloum, Ramzi G. [1 ,2 ]
Thompson, Lindsay A. [1 ,2 ,3 ]
Silver, Natalie L. [4 ]
Shenkman, Elizabeth A. [1 ,2 ]
机构
[1] Univ Florida, Coll Med, UF Dept Hlth Outcomes & Biomed Informat, 2004 Mowry Rd,Room 2238, Gainesville, FL 32610 USA
[2] Univ Florida, UF Inst Child Hlth Policy, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA
[4] Univ Florida, Coll Med, UF Dept Otolaryngol, Gainesville, FL USA
关键词
AGED; 13-17; YEARS; UNITED-STATES; ADVISORY-COMMITTEE; COVERAGE; TRENDS; RECOMMENDATIONS; MULTILEVEL; MORTALITY; BURDEN; RISK;
D O I
10.1016/j.amepre.2021.05.016
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: To direct interventions, the Florida counties with the greatest risk of current and future human papillomavirus-associated cancers were identified by estimating county level (1) percentages of adolescents aged 13-17 years who initiated (>= 1 dose) and were up to date (2-3 doses) for the human papillomavirus vaccine and (2) human papillomavirus-associ-ated cancer incidence rates. Methods: Records were obtained for human papillomavirus vaccinations from the Florida immunization registry (2006-2019), incident cancer cases from the Florida registry (2013-2017), and annual population counts from the Florida Department of Health (2006-2019). In 2020, annual county-level human papillomavirus vaccine initiation, human papillomavirus vaccine up-to-date, and age-adjusted human papillomavirus-associated cancer incidence rates were estimated. Results: Among adolescents aged 13-17 years, average 2018-2019 county-specific human papillomavirus vaccine initiation ranged from 38% to 100% for females and from 34% to 96% for males. Up-to-date estimates ranged from 20% to 72% for females and from 24% to 77% for males. The majority (78%) of counties with initiation and up-to-date estimates within the lowest tercile were located in Northern Florida. County-specific 2013-2017 annualized, adjusted human papillomavirus-associated cancer incidence rates ranged from 0 to 29.8 per 100,000 among females and from 5.4 to 24.1 per 100,000 among males. Counties within the highest tercile for human papillomavirus-associated cancers were primarily (90% for females and 77% for males) located in Northern Florida. Conclusions: Human papillomavirus-associated cancer risk varies widely across Florida counties, with particularly high risk within Northern Florida. Targeting interventions toward counties with low vaccination and high cancer rates may reduce human papillomavirus-associated cancers. (C) 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:812 / 820
页数:9
相关论文
共 58 条
  • [21] Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P625
  • [22] Florida Department of Health, 2019, VACC CHILDR VFC PROG
  • [23] A Systematic Evaluation of Different Methods for Calculating Adolescent Vaccination Levels Using Immunization Information System Data
    Gowda, Charitha
    Dong, Shiming
    Potter, Rachel C.
    Dombkowski, Kevin J.
    Stokley, Shannon
    Dempsey, Amanda F.
    [J]. PUBLIC HEALTH REPORTS, 2013, 128 (06) : 489 - 497
  • [24] Outlier in Analysis of Cancer Mortality by US County
    Hall, Jaclyn M.
    Shenkman, Elizabeth A.
    Fu, Chiung-Shiuan
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (18): : 1910 - 1911
  • [25] Diverse caregivers' HPV vaccine-related awareness and knowledge
    Kepka, Deanna
    Bodson, Julia
    Lai, Djin
    Sanchez-Birkhead, Ana C.
    Davis, France A.
    Lee, Doriena
    Tavake-Pasi, Fahina
    Napia, Edwin
    Villalta, Jeannette
    Mukundente, Valentine
    Mooney, Ryan
    Coulter, Heather
    Stark, Louisa A.
    [J]. ETHNICITY & HEALTH, 2021, 26 (06) : 811 - 826
  • [26] The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
    Khan, MJ
    Castle, PE
    Lorincz, AT
    Wacholder, S
    Sherman, M
    Scott, DR
    Rush, BB
    Glass, AG
    Shiffman, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14): : 1072 - 1079
  • [27] The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015
    Khan, Nazish
    Tomar, Scott L.
    [J]. JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2020, 151 (01) : 51 - 58
  • [28] Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
    Kjaer, Susanne K.
    Frederiksen, Kirsten
    Munk, Christian
    Iftner, Thomas
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (19): : 1478 - 1488
  • [29] Klein R.J., 2001, Healthy People 2010 Stat Notes 20
  • [30] HPV Vaccination and the Risk of Invasive Cervical Cancer
    Lei, Jiayao
    Ploner, Alexander
    Elfstrom, K. Miriam
    Wang, Jiangrong
    Roth, Adam
    Fang, Fang
    Sundstrom, Karin
    Dillner, Joakim
    Sparen, Par
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14) : 1340 - 1348